AR035076A1 - Procedimiento y derivados ester utiles para la preparacion de cefalosporinas - Google Patents
Procedimiento y derivados ester utiles para la preparacion de cefalosporinasInfo
- Publication number
- AR035076A1 AR035076A1 ARP010105608A ARP010105608A AR035076A1 AR 035076 A1 AR035076 A1 AR 035076A1 AR P010105608 A ARP010105608 A AR P010105608A AR P010105608 A ARP010105608 A AR P010105608A AR 035076 A1 AR035076 A1 AR 035076A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- cephalosporins
- derivatives
- preparation
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 2
- 229940124587 cephalosporin Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 3
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- YWWDBCBWQNCYNR-UHFFFAOYSA-N trimethylphosphine Chemical class CP(C)C YWWDBCBWQNCYNR-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006719 (C6-C10) aryl (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001780 cephalosporins Chemical group 0.000 abstract 1
- 150000004292 cyclic ethers Chemical group 0.000 abstract 1
- 230000001351 cycling effect Effects 0.000 abstract 1
- 125000005883 dithianyl group Chemical group 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- -1 trimethylphosphine compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/08—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Procedimiento para preparar un compuesto de fórmula (1) en la que R1 es para-nitrobencilo o alilo; y X es halo; que es útil para preparar cefalosporinas sustituidas con éter cíclico en la posición 3, a partir de compuestos trimetilfosfínicos. También se refieren compuestos útiles en tales procedimientos. Un procedimiento para preparar un compuesto de fórmula (1) en la que R1 es para-nitrobencilo o alilo; y X es halo; porque comprende las etapas de: a) ciclar un compuesto trimetilfosfínico de fórmula (3) en la que R1 es para-nitrobencilo o alilo; y R2 se selecciona entre el grupo compuesto por alquilo C1-6, arilo C6-10, aril C6-10-alquilo C1-6 y ditianilo; en un disolvente; para formar un compuesto de fórmula (2) en la que R1 y R2 son como se definieron anteriormente; y b) hacer reaccionar dicho compuesto de fórmula (2) con un ácido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25101800P | 2000-12-04 | 2000-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035076A1 true AR035076A1 (es) | 2004-04-14 |
Family
ID=22950131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105608A AR035076A1 (es) | 2000-12-04 | 2001-12-03 | Procedimiento y derivados ester utiles para la preparacion de cefalosporinas |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020099205A1 (es) |
| EP (1) | EP1339723B1 (es) |
| JP (1) | JP2004515503A (es) |
| KR (1) | KR100526380B1 (es) |
| CN (1) | CN1243756C (es) |
| AR (1) | AR035076A1 (es) |
| AT (1) | ATE319719T1 (es) |
| AU (2) | AU2392902A (es) |
| BR (1) | BR0115872A (es) |
| CA (1) | CA2436863C (es) |
| CY (1) | CY1104995T1 (es) |
| CZ (1) | CZ20031526A3 (es) |
| DE (1) | DE60117876T2 (es) |
| DK (1) | DK1339723T3 (es) |
| ES (1) | ES2257471T3 (es) |
| HK (1) | HK1059265A1 (es) |
| HU (1) | HUP0400686A3 (es) |
| IL (1) | IL155701A0 (es) |
| MX (1) | MXPA03004938A (es) |
| PL (1) | PL362078A1 (es) |
| PT (1) | PT1339723E (es) |
| RU (1) | RU2237671C1 (es) |
| WO (1) | WO2002046199A1 (es) |
| ZA (1) | ZA200303498B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520293A (ja) * | 2000-12-04 | 2004-07-08 | ファイザー・プロダクツ・インク | セファロスポリン調製に有用なカップリング方法と中間体 |
| KR100830754B1 (ko) * | 2004-03-09 | 2008-05-19 | 화이자 프로덕츠 인코포레이티드 | α-요오도-1-아제티딘아세트산 에스테르 및 트라이알킬포스파이트를 이용한 세팔로스포린 중간체의 제조방법 |
| BRPI0508595A (pt) * | 2004-03-09 | 2007-08-21 | Pfizer Prod Inc | processo para a preparação de intermediários de cefalosporina usando ésteres do ácido alfa-iodo-1-azetidinaacético e trialquil-fosfitos |
| EP1951723B1 (en) | 2005-10-20 | 2017-08-30 | Postech Academy-Industry Foundation | The application using non-covalent bond between a cucurbituril derivative and a ligand |
| CN102372738B (zh) * | 2010-08-14 | 2017-11-10 | 武汉工程大学 | Lj反应在制备维蒂希试剂和草铵膦中的应用 |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| CN111892612A (zh) * | 2020-07-31 | 2020-11-06 | 重庆医药高等专科学校 | 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020329A (en) * | 1990-07-24 | 2000-02-01 | Pzifer Inc. | Cephaloporins and homologues, preparations and pharmaceutical compositions |
| US6001997A (en) * | 1990-07-24 | 1999-12-14 | Bateson; John Hargreaves | Cephalosporins and homologues, preparations and pharmaceutical compositions |
| MY106399A (en) * | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
-
2001
- 2001-11-19 EP EP01999226A patent/EP1339723B1/en not_active Expired - Lifetime
- 2001-11-19 DE DE60117876T patent/DE60117876T2/de not_active Expired - Fee Related
- 2001-11-19 AU AU2392902A patent/AU2392902A/xx active Pending
- 2001-11-19 ES ES01999226T patent/ES2257471T3/es not_active Expired - Lifetime
- 2001-11-19 JP JP2002547936A patent/JP2004515503A/ja active Pending
- 2001-11-19 KR KR10-2003-7007397A patent/KR100526380B1/ko not_active IP Right Cessation
- 2001-11-19 HU HU0400686A patent/HUP0400686A3/hu unknown
- 2001-11-19 PL PL01362078A patent/PL362078A1/xx unknown
- 2001-11-19 PT PT01999226T patent/PT1339723E/pt unknown
- 2001-11-19 CZ CZ20031526A patent/CZ20031526A3/cs unknown
- 2001-11-19 CA CA002436863A patent/CA2436863C/en not_active Expired - Fee Related
- 2001-11-19 IL IL15570101A patent/IL155701A0/xx unknown
- 2001-11-19 AT AT01999226T patent/ATE319719T1/de not_active IP Right Cessation
- 2001-11-19 RU RU2003116520/04A patent/RU2237671C1/ru not_active IP Right Cessation
- 2001-11-19 WO PCT/IB2001/002181 patent/WO2002046199A1/en active IP Right Grant
- 2001-11-19 BR BR0115872-4A patent/BR0115872A/pt not_active IP Right Cessation
- 2001-11-19 CN CNB018195792A patent/CN1243756C/zh not_active Expired - Fee Related
- 2001-11-19 DK DK01999226T patent/DK1339723T3/da active
- 2001-11-19 MX MXPA03004938A patent/MXPA03004938A/es active IP Right Grant
- 2001-11-19 AU AU2002223929A patent/AU2002223929B2/en not_active Ceased
- 2001-12-03 AR ARP010105608A patent/AR035076A1/es active IP Right Grant
- 2001-12-04 US US10/006,579 patent/US20020099205A1/en not_active Abandoned
-
2003
- 2003-05-07 ZA ZA200303498A patent/ZA200303498B/en unknown
-
2004
- 2004-02-17 US US10/781,158 patent/US20040267008A1/en not_active Abandoned
- 2004-03-24 HK HK04102181A patent/HK1059265A1/xx not_active IP Right Cessation
-
2006
- 2006-03-15 CY CY20061100361T patent/CY1104995T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1478094A (zh) | 2004-02-25 |
| HUP0400686A3 (en) | 2010-03-29 |
| DE60117876T2 (de) | 2006-08-31 |
| HUP0400686A2 (hu) | 2004-06-28 |
| DK1339723T3 (da) | 2006-06-12 |
| IL155701A0 (en) | 2003-11-23 |
| ATE319719T1 (de) | 2006-03-15 |
| RU2237671C1 (ru) | 2004-10-10 |
| WO2002046199A1 (en) | 2002-06-13 |
| KR20030070044A (ko) | 2003-08-27 |
| WO2002046199A8 (en) | 2003-06-12 |
| ES2257471T3 (es) | 2006-08-01 |
| US20020099205A1 (en) | 2002-07-25 |
| US20040267008A1 (en) | 2004-12-30 |
| AU2392902A (en) | 2002-06-18 |
| EP1339723B1 (en) | 2006-03-08 |
| AU2002223929B2 (en) | 2007-08-23 |
| CA2436863C (en) | 2007-05-22 |
| ZA200303498B (en) | 2004-05-07 |
| CY1104995T1 (el) | 2009-11-04 |
| CN1243756C (zh) | 2006-03-01 |
| HK1059265A1 (en) | 2004-06-25 |
| PL362078A1 (en) | 2004-10-18 |
| EP1339723A1 (en) | 2003-09-03 |
| CZ20031526A3 (en) | 2004-04-14 |
| PT1339723E (pt) | 2006-06-30 |
| KR100526380B1 (ko) | 2005-11-08 |
| DE60117876D1 (de) | 2006-05-04 |
| MXPA03004938A (es) | 2003-09-10 |
| JP2004515503A (ja) | 2004-05-27 |
| BR0115872A (pt) | 2003-10-28 |
| CA2436863A1 (en) | 2002-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1058362A1 (en) | Imidazopyrimidine derivatives and triazolopyrimidine derivatives | |
| ES2076147T3 (es) | Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion. | |
| ES2008658A4 (es) | Procedimiento de preparacion de monoesteres o diesteres del acido 9,10-dihidro antraceno-11,11-dicarboxilico. | |
| AR061924A1 (es) | Proceso para elaborar 2- amino -5 - halobenzamidas 3- sustituidas | |
| AR035076A1 (es) | Procedimiento y derivados ester utiles para la preparacion de cefalosporinas | |
| NO20031701L (no) | Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener | |
| ATE370736T1 (de) | Verfahren zur herstellung eines piperazinderivates | |
| DE3862901D1 (de) | Thiophenderivat und verfahren zur herstellung. | |
| FR2659328B1 (fr) | Procede de preparation de derives de la 1,5-benzothiazepine. | |
| ATE255103T1 (de) | Verfahren zur herstellung von pyridinmethanol- verbindungen | |
| ES526283A0 (es) | Metodo para preparar derivados de fenilindeno | |
| PE20051021A1 (es) | Derivados de quinolina como inhibidores de selectina | |
| DE60312214D1 (de) | Verfahren zur herstellung von(4e)-5-chloro-2-isopropyl-4-pentensäureester und optischaktivem isomer davon | |
| ATE310735T1 (de) | Verfahren zur herstellung von spirocyclischen tetronsäurederivaten | |
| NO330965B1 (no) | Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt | |
| DE69937988D1 (de) | Verfahren zur herstellung von 3-cephemderivaten | |
| PT86171A (fr) | Procede de preparation de nouveaux derives de l:acide cyclopro-pane carboxylique | |
| KR910004632A (ko) | 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법 | |
| SE7510787L (sv) | Nya kvevehaltiga, polycykliska foreningar, salter derav och deras optiska antipoder, jemte sett for deras framstellning | |
| RU2005123690A (ru) | Способ получения производного бензиламина | |
| SU1169527A3 (ru) | Способ получени хлорформиатов @ - @ -алкиловых эфиров @ - @ - @ -алкилтартроновой кислоты | |
| ATE229011T1 (de) | Verfahren zur herstellung von glycidylethern | |
| ATE129231T1 (de) | Verfahren zur herstellung von optisch aktiven norbornylaminderivaten. | |
| ATE267167T1 (de) | Verfahren zur herstellung von 7-azabicyclo (4.1.0)-hept-3-ene-3-carbonsäureestern | |
| SE8601798D0 (sv) | Process for the preparation of eburnamenine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |